New 5-year data reveals cemiplimab plus chemotherapy significantly enhances survival rates for advanced non-small cell lung cancer patients.
Ana Baramidze, MD
Ana Baramidze, MD, is a the head of the Department of Clinical Research at Todua Clinic in Tblisi, Georgia.
Articles by Ana Baramidze, MD